albuterol has been researched along with Injuries, Spinal Cord in 7 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The charts of CSCI patients admitted to a Level I trauma center from February 2008 through March 2012 were reviewed for demographics, episodes of symptomatic bradycardia (defined as heart rate < 60 beats per minute and systolic blood pressure < 90 mm Hg), use of enteral albuterol, hospital days requiring chronotropic use, and total atropine administered." | 7.80 | Enteral albuterol decreases the need for chronotropic agents in patients with cervical spinal cord injury-induced bradycardia. ( Berry, AJ; Cocanour, CS; Duby, JJ; Evans, CH; Schermer, CR, 2014) |
| "Albuterol administration in ASCI is a safe and feasible treatment for bradycardia, given that no significant side effects, such as hyperglycemia, hypokalemia, or tachycardia, were observed." | 4.12 | Impact of Enteral Albuterol on Bradycardic Events After Acute Cervical Spinal Cord Injury. ( Badjatia, N; Chang, WT; Gupta, S; Hassan, M; Jenkins, R; Lim-Hing, K; Massetti, J; Paganelli, P; Pajoumand, M; Parikh, G; Schwartzbauer, G; Stein, D, 2022) |
| "The charts of CSCI patients admitted to a Level I trauma center from February 2008 through March 2012 were reviewed for demographics, episodes of symptomatic bradycardia (defined as heart rate < 60 beats per minute and systolic blood pressure < 90 mm Hg), use of enteral albuterol, hospital days requiring chronotropic use, and total atropine administered." | 3.80 | Enteral albuterol decreases the need for chronotropic agents in patients with cervical spinal cord injury-induced bradycardia. ( Berry, AJ; Cocanour, CS; Duby, JJ; Evans, CH; Schermer, CR, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lim-Hing, K | 1 |
| Massetti, J | 1 |
| Pajoumand, M | 1 |
| Gupta, S | 1 |
| Jenkins, R | 1 |
| Hassan, M | 1 |
| Paganelli, P | 1 |
| Parikh, G | 1 |
| Chang, WT | 1 |
| Schwartzbauer, G | 1 |
| Stein, D | 1 |
| Badjatia, N | 1 |
| Evans, CH | 1 |
| Duby, JJ | 1 |
| Berry, AJ | 1 |
| Schermer, CR | 1 |
| Cocanour, CS | 1 |
| Rollstin, A | 1 |
| Carey, MC | 1 |
| Doherty, G | 1 |
| Tawil, I | 1 |
| Marinaro, J | 1 |
| Reardon, CC | 1 |
| Christiansen, D | 1 |
| Barnett, ED | 1 |
| Cabral, HJ | 1 |
| Vaidyanathan, S | 1 |
| Watt, JW | 1 |
| Soni, BM | 1 |
| Krishnan, KR | 1 |
| Murphy, RJ | 1 |
| Hartkopp, A | 1 |
| Gardiner, PF | 1 |
| Kjaer, M | 1 |
| Béliveau, L | 1 |
| Rosenberg, NM | 1 |
| Posner, JC | 1 |
| Waltzman, ML | 1 |
| Bhende, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Comparison of Three Methods for Improving Expiratory Cough Flow and Lung Volume in Children With Neuromuscular Diseases[NCT02342132] | 40 participants (Actual) | Interventional | 2014-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for albuterol and Injuries, Spinal Cord
| Article | Year |
|---|---|
Intrapulmonary percussive ventilation vs incentive spirometry for children with neuromuscular disease.
Topics: Absenteeism; Adolescent; Adult; Albuterol; Anti-Bacterial Agents; Bronchodilator Agents; Child; Drug | 2005 |
Salbutamol effect in spinal cord injured individuals undergoing functional electrical stimulation training.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Biopsy; Body Weight; Combined Modality Therapy; Double-B | 1999 |
5 other studies available for albuterol and Injuries, Spinal Cord
| Article | Year |
|---|---|
Impact of Enteral Albuterol on Bradycardic Events After Acute Cervical Spinal Cord Injury.
Topics: Adolescent; Adult; Aged; Albuterol; Bradycardia; Cervical Cord; Female; Humans; Hyperglycemia; Hypok | 2022 |
Enteral albuterol decreases the need for chronotropic agents in patients with cervical spinal cord injury-induced bradycardia.
Topics: Administration, Oral; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Bradycardia; Cerv | 2014 |
Oral albuterol to treat symptomatic bradycardia in acute spinal cord injury.
Topics: Administration, Oral; Adult; Albuterol; Bradycardia; Bronchodilator Agents; Female; Humans; Male; Mi | 2016 |
Intravenous salbutamol treatment for penile erection arising during cystoscopy of cervical spinal cord injury patients.
Topics: Adrenergic beta-Antagonists; Albuterol; Blood Pressure; Cystoscopy; Humans; Injections, Intravenous; | 1996 |
To go by the books.
Topics: Accidents, Traffic; Albuterol; Asthma; Bronchodilator Agents; Cervical Vertebrae; Child; Child, Pres | 2000 |